601 related articles for article (PubMed ID: 29025709)
1. Reduction of In-Stent Restenosis by Cholesteryl Ester Transfer Protein Inhibition.
Wu BJ; Li Y; Ong KL; Sun Y; Shrestha S; Hou L; Johns D; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2333-2341. PubMed ID: 29025709
[TBL] [Abstract][Full Text] [Related]
2. Cholesteryl ester transfer protein inhibition enhances endothelial repair and improves endothelial function in the rabbit.
Wu BJ; Shrestha S; Ong KL; Johns D; Hou L; Barter PJ; Rye KA
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):628-36. PubMed ID: 25633313
[TBL] [Abstract][Full Text] [Related]
3. The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits.
Wu BJ; Li Y; Ong KL; Sun Y; Johns D; Barter PJ; Rye KA
Sci Rep; 2019 Nov; 9(1):16183. PubMed ID: 31700015
[TBL] [Abstract][Full Text] [Related]
4. Increasing HDL levels by inhibiting cholesteryl ester transfer protein activity in rabbits with hindlimb ischemia is associated with increased angiogenesis.
Wu BJ; Shrestha S; Ong KL; Johns D; Dunn LL; Hou L; Barter PJ; Rye KA
Int J Cardiol; 2015 Nov; 199():204-12. PubMed ID: 26204569
[TBL] [Abstract][Full Text] [Related]
5. A successful experimental model for intimal hyperplasia prevention using a resveratrol-delivering balloon.
Tolva V; Mazzola S; Zerbi P; Casana R; Albertini M; Calvillo L; Selmin F; Cilurzo F
J Vasc Surg; 2016 Mar; 63(3):788-94. PubMed ID: 25446284
[TBL] [Abstract][Full Text] [Related]
6. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of smooth muscle cell proliferation and endothelial regeneration after vascular injury and stenting: approach to therapy.
Curcio A; Torella D; Indolfi C
Circ J; 2011; 75(6):1287-96. PubMed ID: 21532177
[TBL] [Abstract][Full Text] [Related]
8. Remodeling of rabbit abdominal aorta and Cx43 gap junctions after stent placement: effect of balloon injury plus cholesterol-enriched diet.
Hung TC; Lu SK; Su CH; Wu YJ; Hsieh CL; Lee WH; Tsai CH; Yeh HI
Int Angiol; 2012 Feb; 31(1):62-9. PubMed ID: 22330626
[TBL] [Abstract][Full Text] [Related]
9. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
[TBL] [Abstract][Full Text] [Related]
10. Effects of pentoxifylline on the vascular response to injury after angioplasty in rabbit iliac arteries.
Busk M; Mertz H; Espersen GT; Rasmussen K; Maeng M
Basic Res Cardiol; 2008 May; 103(3):257-64. PubMed ID: 18087666
[TBL] [Abstract][Full Text] [Related]
11. Opposing Actions of AKT (Protein Kinase B) Isoforms in Vascular Smooth Muscle Injury and Therapeutic Response.
Jin Y; Xie Y; Ostriker AC; Zhang X; Liu R; Lee MY; Leslie KL; Tang W; Du J; Lee SH; Wang Y; Sessa WC; Hwa J; Yu J; Martin KA
Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2311-2321. PubMed ID: 29025710
[TBL] [Abstract][Full Text] [Related]
12. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
[TBL] [Abstract][Full Text] [Related]
13. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
[TBL] [Abstract][Full Text] [Related]
14. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
15. Anacetrapib, but not evacetrapib, impairs endothelial function in CETP-transgenic mice in spite of marked HDL-C increase.
Simic B; Mocharla P; Crucet M; Osto E; Kratzer A; Stivala S; Kühnast S; Speer T; Doycheva P; Princen HM; van der Hoorn JW; Jukema JW; Giral H; Tailleux A; Landmesser U; Staels B; Lüscher TF
Atherosclerosis; 2017 Feb; 257():186-194. PubMed ID: 28152406
[TBL] [Abstract][Full Text] [Related]
16. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cholesteryl ester transfer protein increases cholesteryl ester content of large HDL independently of HDL-to-HDL homotypic transfer: in vitro vs in vivo comparison using anacetrapib and dalcetrapib.
Johns DG; Chen Y; Wang SP; Castro-Perez J; Previs SF; Roddy TP
Eur J Pharmacol; 2015 Sep; 762():256-62. PubMed ID: 26049012
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
[TBL] [Abstract][Full Text] [Related]
19. Fludarabine prevents smooth muscle proliferation in vitro and neointimal hyperplasia in vivo through specific inhibition of STAT-1 activation.
Torella D; Curcio A; Gasparri C; Galuppo V; De Serio D; Surace FC; Cavaliere AL; Leone A; Coppola C; Ellison GM; Indolfi C
Am J Physiol Heart Circ Physiol; 2007 Jun; 292(6):H2935-43. PubMed ID: 17293493
[TBL] [Abstract][Full Text] [Related]
20. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
Huang C; Zhou M; Zheng X
J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
